ProFoldin Protein Folding Services

Protagen uses its proprietary SeroTag biomarker platform to identify disease specific autoantibodies and is on target to become the leading provider of autoimmune diagnostic products, specifically targeting diseases with an unmet need for effective diagnostics. With pioneering bioscience techniques, extensive scientific expertise and a broad patent portfolio, Protagen works to develop its own diagnostic pipeline and partners with other organizations to develop and implement new companion diagnostic tools for better personalized treatment strategies.

Pronota has developed and implemented an integrated protein biomarker pipeline applying protein chemistry techniques, advanced separation sciences and high-end mass spectrometry. The two components, MASStermind for low abundance protein biomarker discovery and MASSterclass for antibody free, multiplex protein assay development aimto provide a solution for the discovery and verification of high value biomarkers for drug and diagnostic development.

Proteomics is widely viewed as the cornerstone of future success in drug discovery and clinical diagnostics, but the complexity of protein molecules and their interactions requires new tools to find and understand biomarkers and protein functions. A critical step in the research process is to properly prepare the molecular sample before analysis can begin. Proteopure, Inc.'s technology is the foundation of a simple laboratory "kit" that fills unmet research needs.nProteopure developed and is now marketing sample protein preparation kits. In addition, Proteopure markets complementary products where there is overlapping customer synergy. These other products include a kit for membrane sample preparation, a kit for measuring protein concentration, fluorescent nanoclusters and beads for labeling proteins, and fluorescent tagged genes for measuring protein expression and location.

Kemp Proteins is a provider of gene-to-protein bioservices. The company's team of protein problem-solvers delivers services that optimize productivity and mitigate risk for life sciences professionals developing protein-based products, including human and veterinary biopharmaceuticals, vaccines, and diagnostics. The company was formerly known as Kempbio and rebranded to Kemp Proteins in March 2019. Kemp Proteins was founded in 2008 and is based in Frederick, Maryland. It operates as a subsidiary of Six.02 Bioservices.

IIT Research Institute (IITRI) is a contract research organization (CRO) that aims to provide non-clinical toxicology and other drug development services to government and industry. IITRI offers particular expertise in oncologics drug development, inhalation toxicology and technology, carcinogenesis and cancer prevention, and biodefense. IITRI's Drug Discovery Division is a research-based group whose focus is the design and synthesis of new small molecule therapeutics for cancer and infectious disease.

BioAxone is a privately owned neuroscience company engaged in the development and commercialization of technologies that target Rho signaling. Established in April 2000 and headquartered in Montreal, Canada, BioAxone has demonstrated expertise in recombinant protein product development and has a focused small molecule program.